Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Rhythm Biosciences Ltd. ( (AU:RHY) ) is now available.
Rhythm Biosciences Limited has applied to the ASX for quotation of 1,000,000 new ordinary fully paid shares, with an issue date of 16 January 2026. The additional securities, issued under a previously announced transaction, will expand the company’s listed share base and may modestly increase liquidity for existing and new investors.
The most recent analyst rating on (AU:RHY) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Rhythm Biosciences Ltd. stock, see the AU:RHY Stock Forecast page.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Limited is an ASX-listed biotechnology company focused on developing diagnostic solutions, with its ordinary fully paid shares traded under the ticker RHY on the Australian Securities Exchange.
Average Trading Volume: 466,433
Technical Sentiment Signal: Buy
Current Market Cap: A$45.5M
See more insights into RHY stock on TipRanks’ Stock Analysis page.